Patent details

Basic Information

Publication number:

EP3246018

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171693013

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION

French Title of Invention:

COMPOSITION PHARMACEUTIQUE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG

SPC Number:

Dates

Filing date:

29/09/2011

Grant date:

03/11/2021

EP Publication Date:

22/11/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/11/2021

EP B1 Publication Date:

03/11/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/09/2022

Expiration date:

29/09/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/10/2021

 

 

Name:

Ferring B.V.

Address:

Polaris Avenue 144, 2132 JX Hoofddorp, Netherlands (NL)

Inventor

1

Name:

WISNIEWSKI, Kazimierz

Address:

United States (US)

2

Name:

MALM, Mattias

Address:

Denmark (DK)

3

Name:

NILSSON, Anders

Address:

Sweden (SE)

4

Name:

SIEKMANN, Britta

Address:

Sweden (SE)

Priority

Priority Number:

10251690

Priority Date:

30/09/2010

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/08; A61K 38/095; A61K 38/12; A61K 47/12; A61K 47/18; A61K 47/20; A61P 15/04;

Publication

European Patent Bulletin

Issue number:

202144

Publication date:

03/11/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages